Aug 25 2016

Check out remarks by our own Lisa Mullineaux, MBS, MS, CGC and Director of Clinical Genetics at Premier Genomics, at a recent Colorado Ovarian Cancer Alliance lecture series on Hereditary genetics, how they may affect treatment, and how hereditary markers may impact family members.

Lisa was the first cancer genetic counselor in Colorado and has been working as a clinical cancer genetic counselor for the last 20 years. Lisa also serves on the board of directors for COCA.

Society guidelines recommend that all women with ovarian cancer and their close relatives should undergo genetic counseling and consider genetic testing


70% of women with hereditary ovarian cancer are at or OVER AGE 50 at diagnosis


1 in 5 women with ovarian cancer have Hereditary Ovarian Cancer caused by inherited mutations in various genes


There are medical management guidelines for individuals with mutations in BRCA1 or BRCA2 and at least EIGHT OTHER GENES that lead to hereditary ovarian cancer.


Genetic testing for hereditary ovarian cancer may influence ovarian cancer treatment and help family members reduce their chances of a diagnosis of ovarian cancer by undergoing risk-reducing measures


We have not yet identified the hereditary cause of ovarian cancer in over 20% of all families with a suspected inherited risk


Almost half of women with ovarian cancer with hereditary ovarian cancer do not have a family history of ovarian cancer/related cancers


Past genetic testing may not have included newly discovered hereditary ovarian cancer genes, so additional testing may be warranted